MX2009011818A - Formulaciones de aminoacido n-halogenado con compuestos anti-inflamatorios. - Google Patents

Formulaciones de aminoacido n-halogenado con compuestos anti-inflamatorios.

Info

Publication number
MX2009011818A
MX2009011818A MX2009011818A MX2009011818A MX2009011818A MX 2009011818 A MX2009011818 A MX 2009011818A MX 2009011818 A MX2009011818 A MX 2009011818A MX 2009011818 A MX2009011818 A MX 2009011818A MX 2009011818 A MX2009011818 A MX 2009011818A
Authority
MX
Mexico
Prior art keywords
amino acid
halogenated amino
inflammatory compounds
formulation
acid formulations
Prior art date
Application number
MX2009011818A
Other languages
English (en)
Inventor
Masood A Chowhan
Wesley Wehsin Han
Original Assignee
Alcon Res Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Res Ltd filed Critical Alcon Res Ltd
Publication of MX2009011818A publication Critical patent/MX2009011818A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención describe una formulación que tiene actividad antimicrobiana que comprende un aminoácido N-halogenado y un compuesto anti-inflamatorio; esta especificación también describe métodos para el tratamiento de una infección de tejido que comprende contactar el tejido infectado con una cantidad farmacéuticamente efectiva de una formulación que comprende un aminoácido N-halogenado y un compuesto anti-inflamatorio; esta especificación describe adicionalmente un método para el tratamiento de infecciones respiratorias que comprende contactar el sitio de la infección respiratoria con una cantidad farmacéuticamente efectiva de una formulación que comprende un aminoácido N-halogenado y un compuesto anti-inflamatorio.
MX2009011818A 2007-05-01 2008-04-30 Formulaciones de aminoacido n-halogenado con compuestos anti-inflamatorios. MX2009011818A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91527707P 2007-05-01 2007-05-01
PCT/US2008/061956 WO2008137444A1 (en) 2007-05-01 2008-04-30 N-halogenated amino acid formulations with anti-inflammatory compounds

Publications (1)

Publication Number Publication Date
MX2009011818A true MX2009011818A (es) 2009-11-13

Family

ID=39495776

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009011818A MX2009011818A (es) 2007-05-01 2008-04-30 Formulaciones de aminoacido n-halogenado con compuestos anti-inflamatorios.

Country Status (15)

Country Link
US (2) US20080275122A1 (es)
EP (1) EP2139519A1 (es)
JP (1) JP2010526085A (es)
KR (1) KR20100017159A (es)
CN (1) CN101687041A (es)
AR (1) AR066372A1 (es)
AU (1) AU2008247788A1 (es)
BR (1) BRPI0810962A2 (es)
CA (1) CA2684186A1 (es)
CL (1) CL2008001282A1 (es)
MX (1) MX2009011818A (es)
RU (1) RU2009144286A (es)
TW (1) TW200901957A (es)
UY (1) UY31058A1 (es)
WO (1) WO2008137444A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110151025A1 (en) * 2008-04-10 2011-06-23 Novabay Pharmaceuticals, Inc. Compositions Comprising N-Halogenated or N,N-Dihalogenated Amine for Treatment and Prophylaxis of Bronchopulmonary Infections
US20110091570A1 (en) * 2008-04-15 2011-04-21 Waldemar Gottardi Compositions and Devices for Antisepsis and Anticoagulation
EP2720665A2 (en) 2011-06-15 2014-04-23 Rls Global Ab Detection and removal of carious dentin tissue.
SE536581C2 (sv) 2012-07-24 2014-03-11 Rls Global Ab Ett kit för behandling av sår eller liknande och ett preparat och metoder därav
US20140227201A1 (en) * 2013-02-13 2014-08-14 Novabay Pharmaceuticals, Inc. Antimicrobial Gel Formulations
KR102253324B1 (ko) * 2019-11-27 2021-05-18 단디바이오사이언스 주식회사 호흡기 질환의 예방, 개선 또는 치료용 조성물

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4910225A (en) * 1988-01-27 1990-03-20 Senju Pharmaceutical Co., Ltd. Locally administrable therapeutic composition for inflammatory disease
US5421818A (en) * 1993-10-18 1995-06-06 Inner Ear Medical Delivery Systems, Inc. Multi-functional inner ear treatment and diagnostic system
US5475034A (en) * 1994-06-06 1995-12-12 Alcon Laboratories, Inc. Topically administrable compositions containing 3-benzoylphenylacetic acid derivatives for treatment of ophthalmic inflammatory disorders
US6156728A (en) * 1996-11-01 2000-12-05 Genentech, Inc. Treatment of inner ear hair cells
WO2001089495A2 (en) * 2000-05-19 2001-11-29 Alcon Laboratories, Inc. Antibiotic compositions containing quinolone derivatives for treatment of the eye, ear and nose
PE20020578A1 (es) * 2000-10-10 2002-08-14 Upjohn Co Una composicion de antibiotico topico para el tratamiento de infecciones oculares
AU2002364051A1 (en) * 2002-01-24 2003-09-02 Children's Medical Center Corporation Anti-cancer combination and use thereof
BRPI0413660A (pt) * 2003-08-18 2006-10-24 Novacal Pharmaceuticals Inc Aminoácidos n,n-di-alogenado e derivados
TWI386201B (zh) * 2005-01-25 2013-02-21 Novabay Pharmaceuticals Inc Ｎ-鹵化胺基酸、ｎ，ｎ-二鹵化胺基酸與其衍生物；以及使用其之組合物與方法
UY31059A1 (es) * 2007-05-01 2008-10-31 Alcon Res Ltd Formulaciones de aminoacido n-halogenado

Also Published As

Publication number Publication date
CA2684186A1 (en) 2008-11-13
BRPI0810962A2 (pt) 2015-01-27
KR20100017159A (ko) 2010-02-16
AR066372A1 (es) 2009-08-12
US20080275122A1 (en) 2008-11-06
RU2009144286A (ru) 2011-06-10
US20100210730A1 (en) 2010-08-19
WO2008137444A1 (en) 2008-11-13
TW200901957A (en) 2009-01-16
JP2010526085A (ja) 2010-07-29
UY31058A1 (es) 2008-10-31
AU2008247788A1 (en) 2008-11-13
EP2139519A1 (en) 2010-01-06
CN101687041A (zh) 2010-03-31
CL2008001282A1 (es) 2009-01-16

Similar Documents

Publication Publication Date Title
BR112012033117A2 (pt) pirazolo[1,5-a]pirimidinas como agentes antivirais
EA201101672A1 (ru) Замещенные производные аминомасляной кислоты в качестве ингибиторов неприлизина
MX2012012225A (es) Profármacos de agentes tearapéuticos de liberación de óxido nítrico.
EA201101671A1 (ru) Замещенные производные аминопропионовой кислоты в качестве ингибиторов неприлизина
MX2009006764A (es) Pirimidinonas biciclicas y usos de la misma.
MY155649A (en) Pyridyloxyindoles inhibitors of vegf-r2 and use thereof for treatment of disease
EA201290191A1 (ru) N1-ПИРАЗОЛОСПИРОКЕТОНОВЫЕ ИНГИБИТОРЫ АЦЕТИЛ-KoA-КАРБОКСИЛАЗЫ
WO2007112000A3 (en) Treatment of pain
EA201101243A1 (ru) 3h-имидазо[4,5-c]пиридин-6-карбоксамиды в качестве противовоспалительных средств
SG159388A1 (en) Antibacterial agents
BR112014015482A2 (pt) compostos carbamato de fenila para uso no alívio ou tratamento de dor e dor neuropática
EA200702387A1 (ru) Имидазохинолины в качестве ингибиторов липидкиназы
WO2012116290A3 (en) Neuroactive 17(20)-z-vinylcyano-substituted steroids, prodrugs thereof, and methods of treatment using same
WO2011106729A3 (en) Pharmaceutical compositions of spiro-oxindole compound for topical administration and their use as therapeutic agents
WO2010107807A3 (en) Compounds for treating inflammation and pain
EA201391720A1 (ru) Замещенные диоксопиперидинилфталимидные производные
EA200970535A1 (ru) Антибактериальные производные хинолина
TW200639159A (en) Treatment of pain
MX2009011818A (es) Formulaciones de aminoacido n-halogenado con compuestos anti-inflamatorios.
WO2008143649A3 (en) Novel oxazolidinone compounds as antiinfective agents
WO2009003719A3 (en) Indane-amine derivatives, their preparation and use as medicaments
MX2009011819A (es) Formulaciones de aminoacido n-halogenado.
TN2014000031A1 (en) Use of organic compound for the treatment of noonan syndrome
WO2007062333A3 (en) New pleuromutilin derivative and its use
EA201390345A1 (ru) Терапевтическое болеутоляющее средство